MCQUADE BARBARA L.
Known title: DirectorCIK: 0001737984
Associated companies
Transaction History
| HBAN | ▲ Buy | Grant | 1,847 | $29K | 1/26/2022 | View on chart |
| HBAN | ▲ Buy | Grant | 1,801 | $29K | 11/1/2021 | View on chart |
| HBAN | ▲ Buy | Grant | 1,847 | $29K | 1/26/2022 | View on chart |
| HBAN | ▲ Buy | Grant | 1,801 | $29K | 11/1/2021 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
HBAN Earnings Outlook and Valuation Concerns Highlighted
Analysts expect Huntington Bancshares' third‑quarter earnings to decline, prompting a view that the stock may trade below its fair value. A recent valuation note suggests the shares are about 21 % undervalued based on current earnings multiples. The company also appears on lists of high‑yield dividend stocks, with a 5.7 % yield, which may attract income‑focused investors. These factors keep the stock in focus as the earnings release approaches.
HBAN Earnings Outlook and Valuation Concerns Highlighted. Analysts expect Huntington Bancshares' third‑quarter earnings to decline, prompting a view that the stock may trade below its fair value. A recent valuation note suggests the shares are about 21 % undervalued based on current earnings multiples. The company also appears on lists of high‑yield dividend stocks, with a 5.7 % yield, which may attract income‑focused investors. These factors keep the stock in focus as the earnings release approaches.